Schweizerhall Pharma - Acino
Schweizerhall Pharma - Acino
Schweizerhall Pharma - Acino
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
<strong>Schweizerhall</strong><br />
<strong>Schweizerhall</strong> is active in the pharmaceutical and chemical industries.<br />
The Business Unit <strong>Pharma</strong>ceuticals is specialized in the development, registration and approval, pro-<br />
duction and packaging of pharmaceuticals, which are no longer under patent protection. With a focus<br />
on solid pharmaceutical forms, the Business Unit <strong>Pharma</strong>ceuticals supplies leading generics firms<br />
throughout Europe.<br />
The Business Unit Chemicals is the leading Swiss supplier of chemical raw materials, intermediates,<br />
specialty chemicals and customized mixtures within comprehensive supply chain solutions. Leverag-<br />
ing its in-depth experience and state-of-the-art infrastructures, the business unit offers global sourcing,<br />
optimal storage, packaging, quality assurance, just-in-time delivery, disposal and recycling.<br />
<strong>Schweizerhall</strong> Group is headquartered in Basel, currently employs approximately 350 staff and gener-<br />
ates annual sales of about CHF 300 million. <strong>Schweizerhall</strong> Holding AG, the Group’s parent, is listed on<br />
SWX Swiss Exchange (Swiss security number: 215941; Telekurs/Bloomberg: SWHN; Reuters:<br />
CESZn).<br />
Contact Calendar<br />
Luzi Andreas von Bidder<br />
CEO <strong>Schweizerhall</strong> Management AG<br />
Tel. +41 43 344 74 74<br />
luzi_andreas.vonbidder@schweizerhall.com<br />
www.schweizerhall.com<br />
<strong>Schweizerhall</strong> Holding AG<br />
4.05.05 Dividend payment<br />
10.05.05 Share split 1:25<br />
Elsässerstrasse 229<br />
CH-4013 Basel<br />
www.schweizerhall.com 2 von 2
Change language